Management
Assessment of women with pre-eclampsia should be performed by a healthcare professional trained in the management of hypertensive disorders of pregnancy.
The only cure for pre-eclampsia is to terminate the pregnancy and deliver the placenta despite possible risk to the foetus. Issues involved include:
- management principles - when to treat (and with what medication), when to admit to hospital, investigations and monitoring
- timing of the delivery
- control of established disease with antihypertensive and anticonvulsant therapy
- disease prevention - role of aspirin and diet (2)
All women who have had pre-eclampsia should be offered a medical review at the postnatal review (6-8 weeks after the birth)
Reference:
- NICE (June 2019). Hypertension in pregnancy - the management of hypertensive disorders during pregnancy
- BMJ. 2006 Feb 25;332(7539):463-8.
Related pages
- Management principles - when to treat, admit to hospital and further tests and monitoring
- Diagnosis, staging and screening
- Timing of delivery
- Hypertension in pregnancy (antihypertensive treatment)
- Anticonvulsant agents in eclampsia
- Prevention of pre-eclampsia
- Postnatal investigation, monitoring and treatment (including after discharge from critical care)
- Steroids in preeclampsia for fetal lung maturation
- Aspirin in prevention of pre-eclampsia
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.